Research Article
Physicochemical and Biological Characterization of a Biosimilar Trastuzumab
Table 5
Relative abundance of trastuzumab subunits by CGE-R. Variation is presented as confidence interval at 95% (
).
| Product | Batch | HC % | NGHC % | LC % |
| Trastuzumab-Probiomed | TZPP12001 | 66.18 ± 0.16 | 0.57 ± 0.06 | 32.89 ± 0.19 | TZPP12002 | 64.46 ± 0.47 | 0.58 ± 0.02 | 34.59 ± 0.32 | TZPP12003 | 65.45 ± 0.97 | 0.50 ± 0.05 | 33.53 ± 1.08 |
| Reference product | B3393B019 | 65.14 ± 0.25 | 0.57 ± 0.03 | 33.93 ± 0.13 | B3417B010 | 66.02 ± 0.27 | 0.52 ± 0.09 | 33.04 ± 0.25 | B3430 | 66.40 ± 0.25 | 0.63 ± 0.01 | 32.46 ± 0.16 |
|
|
HC: heavy chain, NGHC: nonglycosylated heavy chain, and LC: light chain.
|